298 related articles for article (PubMed ID: 29965986)
1. The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients.
Yilmaz B; Spalinger MR; Biedermann L; Franc Y; Fournier N; Rossel JB; Juillerat P; Rogler G; Macpherson AJ; Scharl M
PLoS One; 2018; 13(7):e0199664. PubMed ID: 29965986
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort.
Spalinger MR; Voegelin M; Biedermann L; Zeitz J; Rossel JB; Sulz MC; Frei P; Scharl S; Vavricka SR; Fried M; Rogler G; Scharl M;
Digestion; 2016; 93(3):182-92. PubMed ID: 26928573
[TBL] [Abstract][Full Text] [Related]
3. Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort.
Spalinger MR; Zeitz J; Biedermann L; Rossel JB; Sulz MC; Frei P; Scharl S; Vavricka SR; Fried M; Rogler G; Scharl M;
PLoS One; 2016; 11(7):e0160215. PubMed ID: 27467733
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in
Sharp RC; Beg SA; Naser SA
Front Cell Infect Microbiol; 2018; 8():11. PubMed ID: 29423382
[TBL] [Abstract][Full Text] [Related]
5. Role of
Sharp RC; Beg SA; Naser SA
World J Gastroenterol; 2018 Feb; 24(6):657-670. PubMed ID: 29456405
[TBL] [Abstract][Full Text] [Related]
6. Modulation of
Shaw AM; Qasem A; Naser SA
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445589
[TBL] [Abstract][Full Text] [Related]
7. PTPN2 but not PTPN22 is associated with Crohn's disease in a New Zealand population.
Morgan AR; Han DY; Huebner C; Lam WJ; Fraser AG; Ferguson LR
Tissue Antigens; 2010 Aug; 76(2):119-25. PubMed ID: 20403149
[TBL] [Abstract][Full Text] [Related]
8. PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background.
Glas J; Wagner J; Seiderer J; Olszak T; Wetzke M; Beigel F; Tillack C; Stallhofer J; Friedrich M; Steib C; Göke B; Ochsenkühn T; Karbalai N; Diegelmann J; Czamara D; Brand S
PLoS One; 2012; 7(3):e33682. PubMed ID: 22457781
[TBL] [Abstract][Full Text] [Related]
9. Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease.
Spalinger MR; McCole DF; Rogler G; Scharl M
World J Gastroenterol; 2016 Jan; 22(3):1034-44. PubMed ID: 26811645
[TBL] [Abstract][Full Text] [Related]
10. Presence of PTPN2 SNP rs1893217 Enhances the Anti-inflammatory Effect of Spermidine.
Niechcial A; Butter M; Manz S; Obialo N; Bäbler K; van der Lely L; Lang S; Gottier C; McCole DF; Scharl M; Spalinger MR
Inflamm Bowel Dis; 2020 Jun; 26(7):1038-1049. PubMed ID: 32031616
[TBL] [Abstract][Full Text] [Related]
11. The PTPN22 C1858T (R620W) functional polymorphism in inflammatory bowel disease.
Zaid Y; Senhaji N; Bakhtaoui FZ; Serrano A; Serbati N; Karkouri M; Badre W; Oudghiri M; Martin J; Nadifi S
BMC Res Notes; 2018 Nov; 11(1):783. PubMed ID: 30384859
[TBL] [Abstract][Full Text] [Related]
12. Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy.
Scharl M; Mwinyi J; Fischbeck A; Leucht K; Eloranta JJ; Arikkat J; Pesch T; Kellermeier S; Mair A; Kullak-Ublick GA; Truninger K; Noreen F; Regula J; Gaj P; Pittet V; Mueller C; Hofmann C; Fried M; McCole DF; Rogler G
Inflamm Bowel Dis; 2012 May; 18(5):900-12. PubMed ID: 22021207
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort.
Bank S; Skytt Andersen P; Burisch J; Pedersen N; Roug S; Galsgaard J; Ydegaard Turino S; Brodersen JB; Rashid S; Kaiser Rasmussen B; Avlund S; Bastholm Olesen T; Jürgen Hoffmann H; Kragh Thomsen M; Ostergaard Thomsen V; Frydenberg M; Andersen Nexø B; Sode J; Vogel U; Andersen V
PLoS One; 2014; 9(6):e98815. PubMed ID: 24971461
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune susceptibility gene
Spalinger MR; Shawki A; Chatterjee P; Canale V; Santos A; Sayoc-Becerra A; Scharl M; Tremblay ML; Borneman J; McCole DF
Gut; 2022 Jan; 71(1):89-99. PubMed ID: 33563644
[TBL] [Abstract][Full Text] [Related]
15. Genetic Variations of PTPN2 and PTPN22: Role in the Pathogenesis of Type 1 Diabetes and Crohn's Disease.
Sharp RC; Abdulrahim M; Naser ES; Naser SA
Front Cell Infect Microbiol; 2015; 5():95. PubMed ID: 26734582
[TBL] [Abstract][Full Text] [Related]
16. Association between the PTPN2 gene and Crohn's disease: dissection of potential causal variants.
Marcil V; Mack DR; Kumar V; Faure C; Carlson CS; Beaulieu P; Israel D; Krupoves A; Costea I; Lambrette P; Grimard G; Dong J; Seidman EG; Amre DK; Levy E
Inflamm Bowel Dis; 2013 May; 19(6):1149-55. PubMed ID: 23518806
[TBL] [Abstract][Full Text] [Related]
17. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the Mucosa-Associated Microbiome Linked to the PTPN2 Risk Gene in Patients with Primary Sclerosing Cholangitis and Ulcerative Colitis.
Denoth L; Juillerat P; Kremer AE; Rogler G; Scharl M; Yilmaz B; Bluemel S; On Behalf Of The Swiss Ibd Cohort Study
Microorganisms; 2021 Aug; 9(8):. PubMed ID: 34442830
[TBL] [Abstract][Full Text] [Related]
19. The autoimmune susceptibility gene,
Shawki A; Ramirez R; Spalinger MR; Ruegger PM; Sayoc-Becerra A; Santos AN; Chatterjee P; Canale V; Mitchell JD; Macbeth JC; Gries CM; Tremblay ML; Hsiao A; Borneman J; McCole DF
Gut Microbes; 2020 Nov; 11(6):1547-1566. PubMed ID: 32586195
[TBL] [Abstract][Full Text] [Related]
20. PTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosis.
Spalinger MR; Kasper S; Chassard C; Raselli T; Frey-Wagner I; Gottier C; Lang S; Atrott K; Vavricka SR; Mair F; Becher B; Lacroix C; Fried M; Rogler G; Scharl M
Mucosal Immunol; 2015 Jul; 8(4):918-29. PubMed ID: 25492475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
